1H-1,2,4-Triazole → 4-[1,2,4]Triazol-1-yl-naphthalene-1-carbaldehyde

HRID 388364Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 388364
[NH:1]1[CH:5]=[N:4][CH:3]=[N:2]1.F[C:7]1[C:16]2[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=2)[C:10]([CH:17]=[O:18])=[CH:9][CH:8]=1>CN(C=O)C.C(=O)([O-])[O-].[K+].[K+]>[N:1]1([C:7]2[C:16]3[C:11](=[CH:12][CH:13]=[CH:14][CH:15]=3)[C:10]([CH:17]=[O:18])=[CH:9][CH:8]=2)[CH:5]=[N:4][CH:3]=[N:2]1

Komponenten

5

Versuchsvorschrift

1,2,4-triazole (248 mg) is added to a solution of 4-fluoro-naphthalene-1-carbaldehyde (522 mg) and potassium carbonate (4 mg) in DMF (4 ml): After 3 hours a room temperature, the reaction is quenched with water (40 ml) and ethyl acetate (50 ml). The organic phase is separated and the aqueous phase is extracted two times with ethyl acetate. The organic phases are combined, extracted with water and with a saturated aqueous solution of NaCl, dried over Na2SO4 and concentrated in vacuo. The crude product is purified on a semi-preparative HPLC to yield 4-[1,2,4]triazol-1-yl-naphthalene-1-carbaldehyde (460 mg) as beige crystals. MS (HPLC/MS): 224 (MH+). Retention time: 2.97 min.

Aufarbeitung

  1. customthe reaction is quenched with water (40 ml) and ethyl acetate (50 ml)
  2. customThe organic phase is separated
  3. extractionthe aqueous phase is extracted two times with ethyl acetate
  4. extractionextracted with water and with a saturated aqueous solution of NaCl
  5. dry with materialdried over Na2SO4
  6. concentrationconcentrated in vacuo
  7. customThe crude product is purified on a semi-preparative HPLC

Quellen und Nachweise

ORD-Eintrag
ord-8b0212816bb34f8a86a55ec82397fc7b
Quelldatensatz
uspto-grants-2013_02
Patentnummer
US08377942B2

Notizen zur Reaktion

Wird geladen…